Diclofenac gel — research review 1

...so, with diclofenac gel, a topical NSAID for localized joint pain, the idea is clear: reduce inflammation at the source. But when we talk about its broader impact, especially on aging and all-cause mortality, the picture gets more complex.

Exactly. While topical application reduces some systemic risks, the drug class itself, NSAIDs, has a reputation. And the connection between chronic pain and aging is becoming clearer. We see, for example, that unrelieved pain can actually accelerate biological aging. A GeroScience 2025 study highlighted that painful diabetic neuropathy is linked to accelerated epigenetic aging and telomere shortening compared to painless neuropathy.

So, while diclofenac gel offers localized relief, the broader context of chronic pain is crucial. We’re not just talking about comfort; we’re talking about potential impact on our biological clock. However, the evidence specifically for long-term topical diclofenac's effect on biological aging markers like the epigenetic clock is still emerging.

What we do know is that topical NSAIDs generally show a better safety profile than their oral counterparts regarding serious long-term harms. An Osteoarthritis and Cartilage 2021 review, for instance, found that topical NSAIDs had lower risks of all-cause mortality, cardiovascular disease, and GI bleeding compared to oral NSAIDs.

That’s a key distinction. It means for appropriate, supervised use, especially for localized pain, the topical approach has a clear advantage in avoiding some systemic risks. But the direct impact of diclofenac gel on slowing or reversing biological aging due to pain relief, beyond simply alleviating symptoms, is still a very active area of research. We can't say it definitively alters your epigenetic clock yet, only that untreated pain does.